应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AAA Alternative Access First Priority CLO Bond ETF
未开盘 07-14 16:00:00 EDT
24.98
-0.02
-0.08%
盘后
24.97
+0.00
+0.00%
16:04 EDT
最高
24.99
最低
24.92
成交量
9,904
今开
24.99
昨收
25.00
日振幅
0.28%
总市值
4,246万
流通市值
4,246万
总股本
170.00万
成交额
24.72万
换手率
0.58%
流通股本
170.00万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Calidi Biotherapeutics, Inc.7月14日成交额为451.70万美元
市场透视 · 01:35
Calidi Biotherapeutics, Inc.7月14日成交额为451.70万美元
Calidi Biotherapeutics, Inc.盘中异动 早盘快速跳水8.21%
市场透视 · 07-14 13:31
Calidi Biotherapeutics, Inc.盘中异动 早盘快速跳水8.21%
华侨永亨银行(中国)有限公司2023年绿色金融债券跟踪评级获“AAA”评级
金融界 · 07-14 04:05
华侨永亨银行(中国)有限公司2023年绿色金融债券跟踪评级获“AAA”评级
星展银行(中国)有限公司2023年金融债券跟踪评级获“AAA”评级
金融界 · 07-14 04:05
星展银行(中国)有限公司2023年金融债券跟踪评级获“AAA”评级
东方金诚:维持贵州交通建设集团有限公司主体信用等级为AAA
金融界 · 07-14 03:05
东方金诚:维持贵州交通建设集团有限公司主体信用等级为AAA
中国光大银行股份有限公司2025年金融债券(第二期)获“AAA”评级
金融界 · 07-14 03:05
中国光大银行股份有限公司2025年金融债券(第二期)获“AAA”评级
惠誉确认德国的AAA评级。
金融界 · 07-11
惠誉确认德国的AAA评级。
Calidi Biotherapeutics, Inc.7月10日成交额为1.10亿美元
市场透视 · 07-11
Calidi Biotherapeutics, Inc.7月10日成交额为1.10亿美元
中国广电山东网络有限公司2022年度第一期中期票据跟踪评级获“AAA”评级
金融界 · 07-10
中国广电山东网络有限公司2022年度第一期中期票据跟踪评级获“AAA”评级
Calidi Biotherapeutics, Inc.7月9日成交额为6.88亿美元
市场透视 · 07-10
Calidi Biotherapeutics, Inc.7月9日成交额为6.88亿美元
镇江新区城市建设投资有限公司2023年度第一期中期票据跟踪评级获“AAA”评级
金融界 · 07-09
镇江新区城市建设投资有限公司2023年度第一期中期票据跟踪评级获“AAA”评级
百元助听器正偷走1.2亿老人的听力 其实就是劣质扩音器
金融界 · 07-08
百元助听器正偷走1.2亿老人的听力 其实就是劣质扩音器
Calidi Biotherapeutics, Inc.盘中异动 早盘快速拉升6.08%报0.255美元
市场透视 · 07-08
Calidi Biotherapeutics, Inc.盘中异动 早盘快速拉升6.08%报0.255美元
Calidi Biotherapeutics, Inc.盘中异动 股价大涨5.13%
市场透视 · 07-07
Calidi Biotherapeutics, Inc.盘中异动 股价大涨5.13%
药明康德荣膺MSCI ESG “AAA” 领导力评级 | Bilingual News
药明康德官微 · 07-07
药明康德荣膺MSCI ESG “AAA” 领导力评级 | Bilingual News
蜀道投资集团有限责任公司2024年度第五期中期票据跟踪评级获“AAA”评级
金融界 · 07-07
蜀道投资集团有限责任公司2024年度第五期中期票据跟踪评级获“AAA”评级
甘肃省农垦集团有限责任公司2023年度第一期中期票据(乡村振兴)跟踪评级获“AAA”评级
金融界 · 07-07
甘肃省农垦集团有限责任公司2023年度第一期中期票据(乡村振兴)跟踪评级获“AAA”评级
长江证券多只债券信用等级获联合资信上调至AAA
中访网财观 · 07-04
长江证券多只债券信用等级获联合资信上调至AAA
特变电工股份有限公司2025年面向专业投资者公开发行科技创新可续期公司债券(高成长产业债)(第一期)(品种一)获“AAA”评级
金融界 · 07-04
特变电工股份有限公司2025年面向专业投资者公开发行科技创新可续期公司债券(高成长产业债)(第一期)(品种一)获“AAA”评级
申能股份有限公司2025年面向专业投资者公开发行碳中和绿色科技创新乡村振兴可续期公司债券(第二期)(品种一)获“AAA”评级
金融界 · 07-04
申能股份有限公司2025年面向专业投资者公开发行碳中和绿色科技创新乡村振兴可续期公司债券(第二期)(品种一)获“AAA”评级
加载更多
公司概况
公司名称:
Alternative Access First Priority CLO Bond ETF
所属市场:
ARCA
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"AAA","market":"US","secType":"STK","nameCN":"Alternative Access First Priority CLO Bond ETF","latestPrice":24.975,"timestamp":1752523200000,"preClose":24.995,"halted":0,"volume":9904,"hourTrading":{"tag":"盘后","latestPrice":24.9744,"preClose":24.975,"latestTime":"16:04 EDT","volume":3,"amount":74.925,"timestamp":1752523449424},"delay":0,"floatShares":1700000,"shares":1700000,"eps":0,"marketStatus":"未开盘","change":-0.02,"latestTime":"07-14 16:00:00 EDT","open":24.99,"high":24.99,"low":24.92,"amount":247200.294368,"amplitude":0.002801,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752566400000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":24.995,"sharesOutstanding":1700000,"nav":24.98,"aum":42466000,"dividendRate":0.057658,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":25,"preClose":24.9963,"latestTime":"08:42 EDT","volume":20,"amount":500,"timestamp":1752496949902},"postHourTrading":{"tag":"盘后","latestPrice":24.9744,"preClose":24.975,"latestTime":"16:04 EDT","volume":3,"amount":74.925,"timestamp":1752523449424},"volumeRatio":0.568027},"requestUrl":"/m/hq/s/AAA","defaultTab":"news","newsList":[{"id":"2551324571","title":"Calidi Biotherapeutics, Inc.7月14日成交额为451.70万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551324571","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551324571?lang=zh_cn&edition=full","pubTime":"2025-07-15 09:35","pubTimestamp":1752543326,"startTime":"0","endTime":"0","summary":"美东时间2025年7月14日,Calidi Biotherapeutics, Inc.成交额为451.70万美元,成交额较昨日减少62.86%,当日成交量为758.74万股。Calidi Biotherapeutics, Inc.于2025年7月14日跌23.82%,报0.579美元,该股过去5个交易日涨141.25%,年初至今跌49.65%,过去60日涨19.38%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-14|451.70万|-62.86%|758.74万|#|2025-07-11|1216.10万|-88.92%|1478.40万|#|2025-07-10|1.10亿|-84.04%|1.17亿|#|2025-07-09|6.88亿|4742.81%|6.21亿|#|2025-07-08|1420.02万|4150.60%|4652.67万|Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司,技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715093742a6a9d9f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715093742a6a9d9f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLDI","BK4139","AAA"],"gpt_icon":1},{"id":"2551724181","title":"Calidi Biotherapeutics, Inc.盘中异动 早盘快速跳水8.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551724181","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551724181?lang=zh_cn&edition=full","pubTime":"2025-07-14 21:31","pubTimestamp":1752499877,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时31分,Calidi Biotherapeutics, Inc.股票出现异动,股价快速下跌8.21%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.17%。其相关个股中,Dare Bioscience, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Biomx Inc.涨幅较大,Windtree Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.较为活跃,换手率分别为1599.85%、456.46%、301.50%,振幅较大的相关个股有Biomx Inc.、Barinthus Biotherapeutics Plc、Kairos Pharma, Ltd.,振幅分别为9.04%、7.00%、6.89%。Calidi Biotherapeutics, Inc.公司简介:Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司,技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714213117a6a8efeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714213117a6a8efeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAA","BK4139","CLDI"],"gpt_icon":1},{"id":"2551975114","title":"华侨永亨银行(中国)有限公司2023年绿色金融债券跟踪评级获“AAA”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2551975114","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551975114?lang=zh_cn&edition=full","pubTime":"2025-07-14 12:05","pubTimestamp":1752465919,"startTime":"0","endTime":"0","summary":"2025年7月11日,中诚信国际公布评级报告,华侨永亨银行(中国)有限公司2023年绿色金融债券跟踪评级获“AAA”评级。同时中诚信国际也关注到华侨银行中国面临的诸多挑战,包括盈利能力有待提升、贷款行业集中度较高以及存款结构有待改善等。本次评级也考虑了华侨银行集团对该行的支持。中诚信国际认为,华侨银行有限公司信用水平在未来12~18个月内将保持稳定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/14120551670631.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["161121","AAA"],"gpt_icon":0},{"id":"2551797511","title":"星展银行(中国)有限公司2023年金融债券跟踪评级获“AAA”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2551797511","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551797511?lang=zh_cn&edition=full","pubTime":"2025-07-14 12:05","pubTimestamp":1752465918,"startTime":"0","endTime":"0","summary":"2025年7月14日,中诚信国际公布评级报告,星展银行(中国)有限公司2023年金融债券跟踪评级获“AAA”评级。本次跟踪维持主体及债项上次评级结论,主要基于星展银行(中国)有限公司(以下称“星展中国”、“该行”或“发行人”)亚洲区域化经营网络和综合性服务平台、较为成熟的运营管理和风险管理技术、较好的资产质量以及较为充足的资本等信用优势。同时中诚信国际也关注到星展中国面临的诸多挑战,包括盈利能力有待提升以及存款结构有待继续优化等。本次评级也考虑了星展集团控股有限公司(以下称“星展集团”或“集团”)对该行的支持。中诚信国际认为,星展银行(中国)有限公司信用水平在未来12~18个月内将保持稳定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/14120551670634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AAA"],"gpt_icon":0},{"id":"2551978252","title":"东方金诚:维持贵州交通建设集团有限公司主体信用等级为AAA","url":"https://stock-news.laohu8.com/highlight/detail?id=2551978252","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551978252?lang=zh_cn&edition=full","pubTime":"2025-07-14 11:05","pubTimestamp":1752462343,"startTime":"0","endTime":"0","summary":"资料显示,贵州交通建设集团有限公司主要从事贵州省内交通基础设施项目的投融资、建设及经营管理,实际控制人为贵州省国资委。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/14110551669388.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AAA"],"gpt_icon":0},{"id":"2551978201","title":"中国光大银行股份有限公司2025年金融债券(第二期)获“AAA”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2551978201","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551978201?lang=zh_cn&edition=full","pubTime":"2025-07-14 11:05","pubTimestamp":1752462314,"startTime":"0","endTime":"0","summary":"2025年6月13日,中诚信国际公布评级报告,中国光大银行股份有限公司2025年金融债券(第二期)获“AAA”评级。1997年1月,该行改制成为股份制商业银行,并同时更名为中国光大银行股份有限公司,改制后公司注册资本为人民币28亿元,成为中国国内第一家国有控股并有国际金融组织参股的全国性股份制商业银行。中诚信国际认为,中国光大银行股份有限公司信用水平在未来12~18个月内将保持稳定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/14110551669393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["06818","AAA"],"gpt_icon":0},{"id":"2550964951","title":"惠誉确认德国的AAA评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2550964951","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550964951?lang=zh_cn&edition=full","pubTime":"2025-07-12 05:19","pubTimestamp":1752268750,"startTime":"0","endTime":"0","summary":"惠誉确认德国的AAA评级。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/07/12051951646684.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AAA"],"gpt_icon":0},{"id":"2550032046","title":"Calidi Biotherapeutics, Inc.7月10日成交额为1.10亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550032046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550032046?lang=zh_cn&edition=full","pubTime":"2025-07-11 09:36","pubTimestamp":1752197784,"startTime":"0","endTime":"0","summary":"美东时间2025年7月10日,Calidi Biotherapeutics, Inc.成交额为1.10亿美元,成交额较昨日减少84.04%,当日成交量为1.17亿股。Calidi Biotherapeutics, Inc.于2025年7月10日涨42.57%,报0.998美元,该股过去5个交易日涨326.5%,年初至今跌13.22%,过去60日涨126.82%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-10|1.10亿|-84.04%|1.17亿|#|2025-07-09|6.88亿|4742.81%|6.21亿|#|2025-07-08|1420.02万|4150.60%|4652.67万|#|2025-07-07|33.41万|150.79%|139.31万|#|2025-07-03|13.32万|5.00%|55.11万|Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司,技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711093654a6a29a5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711093654a6a29a5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAA","BK4139","CLDI"],"gpt_icon":1},{"id":"2550933786","title":"中国广电山东网络有限公司2022年度第一期中期票据跟踪评级获“AAA”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2550933786","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550933786?lang=zh_cn&edition=full","pubTime":"2025-07-10 10:05","pubTimestamp":1752113117,"startTime":"0","endTime":"0","summary":"2025年7月9日,中诚信国际公布评级报告,中国广电山东网络有限公司2022年度第一期中期票据跟踪评级获“AAA”评级。中诚信国际认为,中国广电山东网络有限公司信用水平在未来12~18个月内将保持稳定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/10100551600480.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AAA"],"gpt_icon":0},{"id":"2550602906","title":"Calidi Biotherapeutics, Inc.7月9日成交额为6.88亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550602906","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550602906?lang=zh_cn&edition=full","pubTime":"2025-07-10 09:34","pubTimestamp":1752111259,"startTime":"0","endTime":"0","summary":"美东时间2025年7月9日,Calidi Biotherapeutics, Inc.成交额为6.88亿美元,成交额较昨日增加4742.81%,当日成交量为6.21亿股。Calidi Biotherapeutics, Inc.于2025年7月9日涨108.96%,报0.7美元,该股过去5个交易日涨204.35%,年初至今跌39.13%,过去60日涨71.57%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-09|6.88亿|4742.81%|6.21亿|#|2025-07-08|1420.02万|4150.60%|4652.67万|#|2025-07-07|33.41万|150.79%|139.31万|#|2025-07-03|13.32万|5.00%|55.11万|#|2025-07-02|12.69万|67.11%|54.41万|Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司,技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710093712a6a06fa2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710093712a6a06fa2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLDI","BK4139","AAA"],"gpt_icon":0},{"id":"2550061635","title":"镇江新区城市建设投资有限公司2023年度第一期中期票据跟踪评级获“AAA”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2550061635","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550061635?lang=zh_cn&edition=full","pubTime":"2025-07-09 11:05","pubTimestamp":1752030319,"startTime":"0","endTime":"0","summary":"2025年7月8日,中诚信国际公布评级报告,镇江新区城市建设投资有限公司2023年度第一期中期票据跟踪评级获“AAA”评级。中诚信国际认为,镇江新区城市建设投资有限公司信用水平在未来12~18个月内将保持稳定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/09110551578264.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AAA"],"gpt_icon":0},{"id":"2550713825","title":"百元助听器正偷走1.2亿老人的听力 其实就是劣质扩音器","url":"https://stock-news.laohu8.com/highlight/detail?id=2550713825","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550713825?lang=zh_cn&edition=full","pubTime":"2025-07-09 07:38","pubTimestamp":1752017899,"startTime":"0","endTime":"0","summary":"近日,一则“129元‘智能助听器’让母亲听力恶化30%”的新闻登上热搜,引发公众对低价助听器市场乱象的强烈关注。调查发现,部分南方代工厂凭借一张二类医疗器械注册证,为数十个电商品牌贴牌生产“孪生”助听器。讽刺的是,尽管质量问题频发,百元助听器退货率却不足5%。老人往往忍耐不适,等发现听力严重受损时已无法挽回。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://ky.jrj.com.cn/2025/07/09073851572086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AAA"],"gpt_icon":0},{"id":"2549258665","title":"Calidi Biotherapeutics, Inc.盘中异动 早盘快速拉升6.08%报0.255美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549258665","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549258665?lang=zh_cn&edition=full","pubTime":"2025-07-08 22:05","pubTimestamp":1751983544,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日22时05分,Calidi Biotherapeutics, Inc.股票出现波动,股价急速上涨6.08%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.59%。其相关个股中,Prokidney Corp.、Moleculin Biotech, Inc.、Rallybio Corporation涨幅较大,Zyversa Therapeutics, Inc.、Rallybio Corporation、Moleculin Biotech, Inc.较为活跃,换手率分别为853.23%、239.73%、164.76%,振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Moleculin Biotech, Inc.、Prokidney Corp.,振幅分别为70.97%、69.44%、62.64%。Calidi Biotherapeutics, Inc.公司简介:Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司,技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708220544a43e3f43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708220544a43e3f43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AAA","CLDI"],"gpt_icon":0},{"id":"2549530069","title":"Calidi Biotherapeutics, Inc.盘中异动 股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549530069","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549530069?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:37","pubTimestamp":1751895432,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时37分,Calidi Biotherapeutics, Inc.股票出现异动,股价快速上涨5.13%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.69%。其相关个股中,Mustang Bio, Inc.、Artelo Biosciences, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Mustang Bio, Inc.、Artelo Biosciences, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃,换手率分别为1847.21%、816.86%、702.35%,振幅较大的相关个股有Mustang Bio, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Jasper Therapeutics Inc C/Wts 24/09/2026 ,振幅分别为103.36%、52.80%、42.97%。Calidi Biotherapeutics, Inc.公司简介:Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司,技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213712a69b1bbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213712a69b1bbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AAA","CLDI"],"gpt_icon":0},{"id":"2549532294","title":"药明康德荣膺MSCI ESG “AAA” 领导力评级 | Bilingual News","url":"https://stock-news.laohu8.com/highlight/detail?id=2549532294","media":"药明康德官微","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549532294?lang=zh_cn&edition=full","pubTime":"2025-07-07 20:17","pubTimestamp":1751890620,"startTime":"0","endTime":"0","summary":"上海,2025年7月7日 – 近日,药明康德在摩根士丹利资本国际公司最新公布的环境、社会及管治年度评级结果中,首次获评最高评级“AAA”级,成为A股生命健康行业中首家获此认可的企业。MSCI ESG评级旨在衡量一家公司对长期的、与财务相关的ESG风险抵御能力。MSCI ESG评级结果从“AAA”(最高)至“CCC”(最低)共分为7个等级,其中“AAA”和“AA”级被视为行业领先者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-07-07/doc-infesafa9571377.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02359","AAA","603259","159717","MSCI","ESG"],"gpt_icon":0},{"id":"2549306194","title":"蜀道投资集团有限责任公司2024年度第五期中期票据跟踪评级获“AAA”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2549306194","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549306194?lang=zh_cn&edition=full","pubTime":"2025-07-07 11:05","pubTimestamp":1751857518,"startTime":"0","endTime":"0","summary":"2025年6月30日,中诚信国际公布评级报告,蜀道投资集团有限责任公司2024年度第五期中期票据跟踪评级获“AAA”评级。本次跟踪维持主体及债项上次评级结论。中诚信国际认为,蜀道投资集团有限责任公司信用水平在未来12~18个月内将保持稳定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/07110551522786.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AAA"],"gpt_icon":0},{"id":"2549306157","title":"甘肃省农垦集团有限责任公司2023年度第一期中期票据(乡村振兴)跟踪评级获“AAA”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2549306157","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549306157?lang=zh_cn&edition=full","pubTime":"2025-07-07 11:05","pubTimestamp":1751857517,"startTime":"0","endTime":"0","summary":"2025年7月4日,中诚信国际公布评级报告,甘肃省农垦集团有限责任公司2023年度第一期中期票据跟踪评级获“AAA”评级。本次跟踪维持主体及债项上次评级结论,主要基于甘肃省农垦集团有限责任公司业务多元化程度较高、资源控制力很强、土地资源丰富、农业种植板块稳步经营、银行授信充足以及融资渠道畅通等方面的优势。中诚信国际认为,甘肃省农垦集团有限责任公司信用水平在未来12~18个月内将保持稳定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/07110551522788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AAA"],"gpt_icon":0},{"id":"2548636123","title":"长江证券多只债券信用等级获联合资信上调至AAA","url":"https://stock-news.laohu8.com/highlight/detail?id=2548636123","media":"中访网财观","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548636123?lang=zh_cn&edition=full","pubTime":"2025-07-04 17:00","pubTimestamp":1751619600,"startTime":"0","endTime":"0","summary":"来源:中访网财观中访网数据 联合资信评估股份有限公司于2025年6月27日发布最新评级报告,将长江证券股份有限公司发行的\"23长江C1\"\"23长江Y1\"\"24长江Y1\"\"25长江Y1\"四只债券的信用等级由AA+调升至AAA,维持评级展望为稳定。最新评级报告显示,长江证券整体经营正常,财务状况稳健,评级上调将对公司未来发展产生积极影响。此次评级上调预计不会对长江证券的生产经营和偿债能力造成不利影响,反而有助于提升其市场信誉和融资能力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/cj/2025-07-04/doc-infehynr9577323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AAA","BK0183","BK0188","BK0201","000783","BK0276"],"gpt_icon":0},{"id":"2548359852","title":"特变电工股份有限公司2025年面向专业投资者公开发行科技创新可续期公司债券(高成长产业债)(第一期)(品种一)获“AAA”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2548359852","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548359852?lang=zh_cn&edition=full","pubTime":"2025-07-04 13:05","pubTimestamp":1751605511,"startTime":"0","endTime":"0","summary":"2025年5月26日,中诚信国际公布评级报告,特变电工股份有限公司2025年面向专业投资者公开发行科技创新可续期公司债券(第一期)(品种一)获“AAA”评级。同时中诚信国际也关注到多晶硅板块经营压力加大、在建项目未来资金需求大、子公司众多加大管理压力等对其经营和整体信用状况造成的影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/04130551480360.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AAA","600089"],"gpt_icon":0},{"id":"2548866359","title":"申能股份有限公司2025年面向专业投资者公开发行碳中和绿色科技创新乡村振兴可续期公司债券(第二期)(品种一)获“AAA”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2548866359","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548866359?lang=zh_cn&edition=full","pubTime":"2025-07-04 13:05","pubTimestamp":1751605510,"startTime":"0","endTime":"0","summary":"2025年6月9日,中诚信国际公布评级报告,申能股份有限公司2025年面向专业投资者公开发行碳中和绿色科技创新乡村振兴可续期公司债券(第二期)(品种一)获“AAA”评级。同时中诚信国际也关注到公司装机结构以火电机组为主及债务规模呈上升趋势等因素对其经营和整体信用状况造成的影响。资料显示,申能股份有限公司成立于1993年2月22日,由原申能电力开发公司改组而成。2024年公司实现营业总收入296.19亿元,呈持续增长态势。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/04130551480361.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["600642","159790","AAA"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0038},{"period":"1month","weight":0.0008},{"period":"3month","weight":0.0169},{"period":"6month","weight":-0.0062},{"period":"1year","weight":-0.0046},{"period":"ytd","weight":-0.0032}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"","yearOnYearQuotes":[{"month":1,"riseRate":0.8,"avgChangeRate":0.003198},{"month":2,"riseRate":0.6,"avgChangeRate":-0.000156},{"month":3,"riseRate":0,"avgChangeRate":-0.005433},{"month":4,"riseRate":0.8,"avgChangeRate":0.011742},{"month":5,"riseRate":0,"avgChangeRate":-0.013265},{"month":6,"riseRate":0.6,"avgChangeRate":0.000559},{"month":7,"riseRate":0.6,"avgChangeRate":0.001243},{"month":8,"riseRate":0.25,"avgChangeRate":0.000637},{"month":9,"riseRate":0.5,"avgChangeRate":-0.000735},{"month":10,"riseRate":0.6,"avgChangeRate":0.000411},{"month":11,"riseRate":1,"avgChangeRate":0.003343},{"month":12,"riseRate":0.4,"avgChangeRate":-0.000547}],"exchange":"ARCA","name":"Alternative Access First Priority CLO Bond ETF","nameEN":"Alternative Access First Priority CLO Bond ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Alternative Access First Priority CLO Bond ETF(AAA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Alternative Access First Priority CLO Bond ETF(AAA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Alternative Access First Priority CLO Bond ETF,AAA,Alternative Access First Priority CLO Bond ETF股票,Alternative Access First Priority CLO Bond ETF股票老虎,Alternative Access First Priority CLO Bond ETF股票老虎国际,Alternative Access First Priority CLO Bond ETF行情,Alternative Access First Priority CLO Bond ETF股票行情,Alternative Access First Priority CLO Bond ETF股价,Alternative Access First Priority CLO Bond ETF股市,Alternative Access First Priority CLO Bond ETF股票价格,Alternative Access First Priority CLO Bond ETF股票交易,Alternative Access First Priority CLO Bond ETF股票购买,Alternative Access First Priority CLO Bond ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Alternative Access First Priority CLO Bond ETF(AAA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Alternative Access First Priority CLO Bond ETF(AAA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}